BDBM689062 US20240190893, Compound 6::US20240190893, Compound 7

SMILES Cc1nn(C)c(C)c1-c1c(Cl)ccc2c3CCCOc4cc(CCc5cc(CSCCn(c3C(O)=O)c12)nn5C)cc1cc(F)ccc41

InChI Key InChIKey=FRTWJBQKFZSXBK-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 689062   

TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM689062(US20240190893, Compound 7 | US20240190893, Compoun...)
Affinity DataKi:  0.0560nMAssay Description:This assay evaluated inhibition of the BH3 domain: Mcl-1 interaction by measuring the displacement of Cy5-labeled BIM BH3 peptide (H2N (C/Cy5Mal) WIA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
US Patent

TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM689062(US20240190893, Compound 7 | US20240190893, Compoun...)
Affinity DataKi:  0.0860nMAssay Description:This assay evaluated inhibition of the BH3 domain: Mcl-1 interaction by measuring the displacement of Cy5-labeled BIM BH3 peptide (H2N (C/Cy5Mal) WIA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
US Patent